KimJJeonJYChoiYJ, et al. Characteristics of metastatic brachial plexopathy in patients with breast cancer. Support Care Cancer2020; 28:1913–8.
2.
BowenBCSeidenwurmDJ.Plexopathy. Am J Neuroradiol2008; 29: 400–2.
3.
AhmadABarringtonSMaiseyM, et al. Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients. Br J Cancer1999; 79: 478–82.
4.
CrushABHoweBMSpinnerRJ, et al. Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlation. Radiographics2014; 34: 1987–2007.
5.
PericSLavrnicSBastaI, et al. Significance of magnetic resonance imaging in differential diagnosis of nontraumatic brachial plexopathy. Vojnosanit Pregl2011; 68: 327–31.
6.
ThyagarajanDCascinoTHarmsG.Magnetic resonance imaging in brachial plexopathy of cancer. Neurology1995; 45: 421–7.
7.
HathawayPBMankoffDAMaravillaKR, et al. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience. Radiology1999; 210: 807–14.
8.
ChandraPPurandareNAgrawalA, et al. Clinical utility of (18) F-FDG PET/CT in brachial plexopathy secondary to metastatic breast cancer. Indian J Nucl Med2016; 31: 123.
